or
forgot password

    • cancer clinical trials in round rock, TX

    • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Texas Oncology, PA at Texas Cancer Center Round Rock
    Round Rock, Texas 78681
    Breast Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Texas Oncology, PA at Texas Cancer Center Round Rock
    Round Rock, Texas 78681
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Texas Oncology-Seton Williamson

    Trial Locations
    Texas Oncology-Seton Williamson
    Texas Oncology - Round Rock Cancer Center
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Texas Oncology-Seton Williamson

    Trial Locations
    Texas Oncology-Seton Williamson
    Texas Oncology - Round Rock Cancer Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Texas Oncology, PA at Texas Cancer Center Round Rock

    Trial Locations
    Texas Oncology, PA at Texas Cancer Center Round Rock
    Texas Oncology, PA - Seton Williamson
    Colorectal Cancer
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    Texas Oncology - Round Rock Cancer Center

    Trial Locations
    Texas Oncology - Round Rock Cancer Center
    Texas Oncology Seton Williamson
    Breast Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Texas Oncology Seton Williamson
    Round Rock, Texas 78665
    Multiple Myeloma
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Texas Oncology - Seton Williamson
    Round Rock, Texas 78665
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Texas Oncology - Round Rock Cancer Center
    Round Rock, Texas 78681
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Texas Oncology - Seton-Williamson

    Trial Locations
    Texas Oncology - Seton-Williamson
    Texas Oncology - Round Rock
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
    Texas Oncology - Seton Williamson
    Round Rock, Texas 78665
    Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Texas Oncology - Round Rock Cancer Center

    Trial Locations
    Texas Oncology - Round Rock Cancer Center
    Scott and White Healthcare Round Rock
    Breast Cancer
    A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
    Texas Oncology - Seton Williamson
    Round Rock, Texas 78665
    Hodgkin Disease
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    Texas Oncology - Seton-Williamson

    Trial Locations
    Texas Oncology - Seton-Williamson
    Texas Oncology - Round Rock
    Prostate Cancer
    A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)
    Scott and White Healthcare- Round Rock
    Round Rock, Texas 76559
    Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC